Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma

Jane Yanagawa1, Tonya C Walser, Li X Zhu

  • 1Lung Cancer Research Program, Division of Pulmonary and Critical Care Medicine, 10833 Le Conte Avenue, 37-131 CHS, Los Angeles, CA 90095-1690, USA.

Abstract

Insights

Snail protein promotes non-small cell lung cancer (NSCLC) progression and reduces patient survival. Its overexpression increases tumor burden and angiogenesis, which can be blocked by targeting CXCR2 ligands.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Snail is a transcriptional repressor linked to epithelial-mesenchymal transition, invasion, and metastasis.
  • The role of Snail in other malignant phenotypes, particularly in non-small cell lung cancer (NSCLC), remains underexplored.

Purpose of the Study:

  • To investigate the specific contributions of Snail to the progression of non-small cell lung cancer (NSCLC).

Main Methods:

  • Immunohistochemistry and tissue microarray analysis of human NSCLC tissues to correlate Snail expression with survival.
  • In vivo evaluation of Snail-overexpressing NSCLC cell lines in murine tumor models.
  • Gene expression microarray analysis to identify Snail-associated differential gene expression.

Main Results:

  • Snail is upregulated in human NSCLC and correlates with decreased survival.
  • Snail overexpression in NSCLC models increased primary tumor burden and showed a trend toward increased metastases.
  • Snail overexpression promoted angiogenesis via CXCL8 and CXCL5, and this effect was abrogated by CXCR2 blockade.

Conclusions:

  • Snail upregulation is a significant factor in human NSCLC progression.
  • Snail promotes tumor progression in NSCLC, at least partly, through the mediation of CXCR2 ligands.
  • Targeting CXCR2 ligands represents a potential therapeutic strategy for Snail-driven NSCLC.